Related Experiment Video
Updated: Nov 24, 2025

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
Published on: January 22, 2021
FENDRR Sponges miR-424-5p to Inhibit Cell Proliferation, Migration and Invasion in Colorectal Cancer
Chuan Cheng1, Huixia Li1, Jiujian Zheng1
1Department of Colorectal and Anal Surgery, Lishui Municipal Central Hospital, Zhejiang Province, China.
Objective:
LncRNAs are non-coding RNAs exerting vital roles in the occurrence and development of various cancer types. This study tended to describe the expression pattern of FENDRR in colorectal cancer (CRC), and further investigate the role of FENDRR in CRC cell biological behaviors.
Methods:
Gene expression profile of colon cancer was accessed from the TCGA database, and then processed for differential analysis for identification of differentially expressed lncRNAs and miRNAs. Some in vitro experiments like qRT-PCR, MTT, colony formation assay, wound healing assay and Transwell assay were performed to assess the effect of FENDRR on cell biological behaviors. Dual-luciferase reporter assay was conducted to further validate the targeting relationship between FENDRR and miR-424-5p, and rescue experiments were carried out for determining the mechanism of FENDRR/miR-424-5p underlying the proliferation, migration and invasion of CRC cells.
Results:
Bioinformatics analysis suggested that FENDRR was significantly down-regulated in CRC tissue, and low FENDRR was intimately correlated to poor prognosis. FENDRR overexpression could greatly inhibit cell proliferation, migration and invasion. Besides, there was a negative correlation between FENDRR and miR-424-5p. Dual-luciferase reporter assay indicated that miR-424-5p was a direct target of FENDRR. Rescue experiments discovered that FENDRR exerted its role in cell proliferation, migration and invasion in CRC via targeting miR-424-5p.
Conclusion:
FENDRR is poorly expressed in CRC tissue and cells, and low FENDRR is responsible for the inhibition of cell proliferation, migration and invasion of CRC by means of targeting miR-424-5p.
Insights
Long non-coding RNAs (lncRNAs) like FENDRR are crucial in cancer. This study found FENDRR is downregulated in colorectal cancer (CRC), inhibiting CRC cell proliferation, migration, and invasion by targeting miR-424-5p.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) play significant roles in various cancers.
- FENDRR is a lncRNA whose expression and function in colorectal cancer (CRC) require further investigation.
Purpose of the Study:
- To investigate the expression pattern of FENDRR in colorectal cancer (CRC).
- To explore the role of FENDRR in the biological behaviors of CRC cells.
- To elucidate the underlying molecular mechanism involving miR-424-5p.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA) database for gene expression analysis.
- Performed in vitro experiments including qRT-PCR, MTT, colony formation, wound healing, and Transwell assays.
- Conducted dual-luciferase reporter and rescue experiments to validate targeting and mechanism.
Main Results:
- FENDRR was significantly downregulated in CRC tissues and correlated with poor prognosis.
- FENDRR overexpression inhibited CRC cell proliferation, migration, and invasion.
- FENDRR directly targeted miR-424-5p, mediating its effects on CRC cell behaviors.
Conclusions:
- FENDRR is underexpressed in colorectal cancer (CRC).
- FENDRR functions as a tumor suppressor in CRC by inhibiting cell proliferation, migration, and invasion.
- The FENDRR/miR-424-5p axis is a key mechanism regulating CRC progression.
More Related Videos
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
Cancer Cell Migration through Invadopodia
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal